Talk:Vaccine Taskforce
Add topicAppearance
| This is the talk page for discussing improvements to the Vaccine Taskforce article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
| This article is written in British English, which has its own spelling conventions (colour, travelled, centre, defence, artefact, analyse) and some terms may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
| This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| The contentious topics procedure applies to this article. This article relates to COVID-19. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. |
Start a discussion about improving the Vaccine Taskforce page
Talk pages are where people discuss how to make content on Wikipedia the best that it can be. You can use this page to start a discussion with others about how to improve the "Vaccine Taskforce" page.
Categories:
- Wikipedia articles that use British English
- Start-Class COVID-19 articles
- Low-importance COVID-19 articles
- WikiProject COVID-19 articles
- Start-Class medicine articles
- Low-importance medicine articles
- All WikiProject Medicine pages
- Start-Class United Kingdom articles
- Unknown-importance United Kingdom articles
- WikiProject United Kingdom articles